LRRK2 and Parkinson disease: An incomplete understanding of LRRK2 function also affects the development of biomarkers that can be used as target engagement markers in clinical trials, or importantly, the identification of sporadic PD patients with LRRK2 dysfunction, who may be stratified into LRRK2 therapeutic trials.